MX2015014707A - Pharmaceutical composition and process for obtaining injectable esomeprazole. - Google Patents

Pharmaceutical composition and process for obtaining injectable esomeprazole.

Info

Publication number
MX2015014707A
MX2015014707A MX2015014707A MX2015014707A MX2015014707A MX 2015014707 A MX2015014707 A MX 2015014707A MX 2015014707 A MX2015014707 A MX 2015014707A MX 2015014707 A MX2015014707 A MX 2015014707A MX 2015014707 A MX2015014707 A MX 2015014707A
Authority
MX
Mexico
Prior art keywords
pharmaceutical composition
esomeprazole
injectable
obtaining
obtaining injectable
Prior art date
Application number
MX2015014707A
Other languages
Spanish (es)
Inventor
Daniel Walls Flores Oliver
Rodríguez Hernández Ramón
Montoya Rete Jesus
Original Assignee
Laboratorios Liomont S A De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Liomont S A De C V filed Critical Laboratorios Liomont S A De C V
Priority to MX2015014707A priority Critical patent/MX2015014707A/en
Publication of MX2015014707A publication Critical patent/MX2015014707A/en

Links

Abstract

The present disclosure is related to a pharmaceutical composition to be administered parenterally and be used for the treatment of problems related to gastric disorders; using a specific pH adjustment in a range of 10.0 - 12.0, being sodium esomeprazole the specific active ingredient in a lyophilisate to be reconstituted, in which a bulking and/or an antioxidant agent may be used.
MX2015014707A 2015-10-20 2015-10-20 Pharmaceutical composition and process for obtaining injectable esomeprazole. MX2015014707A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX2015014707A MX2015014707A (en) 2015-10-20 2015-10-20 Pharmaceutical composition and process for obtaining injectable esomeprazole.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2015014707A MX2015014707A (en) 2015-10-20 2015-10-20 Pharmaceutical composition and process for obtaining injectable esomeprazole.

Publications (1)

Publication Number Publication Date
MX2015014707A true MX2015014707A (en) 2017-04-19

Family

ID=59067363

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015014707A MX2015014707A (en) 2015-10-20 2015-10-20 Pharmaceutical composition and process for obtaining injectable esomeprazole.

Country Status (1)

Country Link
MX (1) MX2015014707A (en)

Similar Documents

Publication Publication Date Title
MX2018003331A (en) Administration of deuterated cftr potentiators.
EA201992722A1 (en) N2, N4-DIPHENYLPYRIMIDINE-2,4-DIAMINE DERIVATIVE, METHOD FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITION CONTAINING IT AS AN ACTIVE INGREDIENT, FOR PREVENTION OF TREATMENT AND TREATMENT
PH12019502577A1 (en) Substituted indoline derivatives as dengue viral replication inhibitors
PH12019502201A1 (en) Substituted indoline derivatives as dengue viral replication inhibitors
PH12018502077A1 (en) Substituted indoline derivatives as dengue viral replication inhibitors
PH12019502095A1 (en) Substituted indoline derivatives as dengue viral replication inhibitors
PH12019502559A1 (en) Substituted indoline derivatives as dengue viral replication inhibitors
MX2018011788A (en) Substituted indoline derivatives as dengue viral replication inhibitors.
MX2015010829A (en) Therapeutic compounds and uses thereof.
PH12019502150A1 (en) Compounds and methods for the treatment of parasitic diseases
MA39765A (en) Pharmaceutical formulations of a pan-raf kinase inhibitor, processes for their preparation, and methods of use
PH12016501519A1 (en) Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions
MX2021002322A (en) Novel methods.
PH12019500618A1 (en) Pharmaceutical composition and method for treatment of non-alcoholic fatty liver disease
NZ726132A (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
MX2015014707A (en) Pharmaceutical composition and process for obtaining injectable esomeprazole.
MX2018008443A (en) Pharmaceutical composition comprising nebivolol with improved dissolution rate.
MX2018001528A (en) Pharmaceutical composition comprising sumatripan for treating migraine.
PH12016502107A1 (en) Combination of brexpiprazole and nalmefene and use thereof for treating substance-related disorders
ZA202200330B (en) Pharmaceutical composition of imatinib
EA202090268A1 (en) CARBOXAMIDS AS SODIUM CHANNEL MODULATORS